Novartis AG
NVSEF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001114448
No open-market purchases or sales by Novartis AG insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $6.28M in total; no superinvestor holds it.
Other share classesNVS
Q2 2024 vs. Q1 2024
How the institutions holding Novartis AG changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 3 | 3 | 0 |
| Shares | 193.5K | 310.1K | +116.6K (+60.3%) |
| Value | $18.8M | $33.2M | +$14.4M (+76.8%) |
New holders (1)
Institutions that held Novartis AG at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Partners Capital Investment Group, LLP | 45,436 | $4.86M | 0.08% |
Sold out (1)
Institutions that held Novartis AG at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Promethos Capital, LLC | 1,391 | $134.6K |